Evidence map›Paper›PMID 35498050›Full record

Trial reportFrontiers in cardiovascular medicine2022

L-Arginine Improves Cognitive Impairment in Hypertensive Frail Older Adults.

Pasquale Mone, Antonella Pansini, Stanislovas S Jankauskas, Fahimeh Varzideh, Urna Kansakar, Angela Lombardi, Valentina Trimarco, Salvatore Frullone, Gaetano Santulli

Registry-linked trialOpen access · goldAbstract readClinical Trial
In one paragraph

Trial report in Frontiers in cardiovascular medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04962841 (Cognitive and Physical Impairment in Frail Older Adults), which is not on this map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04962841 unknown statusnot on this map

Cognitive and Physical Impairment in Frail Older Adults

TypeobservationalSponsorUniversity of Campania Luigi VanvitelliRan2020 to 2023Enrolled485ConditionsFrailtyArmsNutraceuticals
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Pasquale MoneDepartment of Medicine, Albert Einstein College of Medicine, New York, NY, United States.
Antonella PansiniAzienda Sanitaria Locale (ASL) Avellino, Avellino, Italy.
Stanislovas S JankauskasDepartment of Medicine, Albert Einstein College of Medicine, New York, NY, United States.
Fahimeh VarzidehDepartment of Medicine, Albert Einstein College of Medicine, New York, NY, United States.
Urna KansakarDepartment of Medicine, Albert Einstein College of Medicine, New York, NY, United States.
Angela LombardiDepartment of Medicine, Albert Einstein College of Medicine, New York, NY, United States.
Valentina TrimarcoUniversity of Naples "Federico II", Naples, Italy.
Salvatore FrulloneAzienda Sanitaria Locale (ASL) Avellino, Avellino, Italy.
Gaetano SantulliDepartment of Medicine, Albert Einstein College of Medicine, New York, NY, United States.
Albert Einstein College of Medicine · USASL Roma · ITUniversity of Naples Federico II · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cognitive impairment is a prevailing event in hypertensive patients and in frail older adults. Endothelial dysfunction has been shown to underlie both hypertension and cognitive dysfunction. Our hypothesis is that L-Arginine, which is known to ameliorate endothelial dysfunction, could counteract cognitive impairment in a high-risk population of hypertensive frail older adults. We designed a clinical trial to verify the effects of 4-weeks oral supplementation of L-Arginine on global cognitive function of hypertensive frail older patients. The study was successfully completed by 35 frail hypertensive elderly patients assigned to L-Arginine and 37 assigned to placebo. At follow-up, we found a significant difference in the Montreal Cognitive Assessment (MoCA) test score between the L-Arginine treated group and placebo ( Clinical Trial Registration: www.ClinicalTrials.gov, identifier: NCT04962841.

Indexed as

cardiac rehabilitationcognitive impairmentendothelial (dys)functionfrail adultsfrailtyL-ArgL-Arginine

Identifiers

PMID35498050
PMCPMC9039514
OpenAlexW4223437872

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.